These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 267157)

  • 1. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic disposition of antipyrine in patients with lung cancer.
    Tschanz C; Hignite CE; Huffman DH; Azarnoff DL
    Cancer Res; 1977 Nov; 37(11):3881-6. PubMed ID: 908027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on antipyrine metabolism in patients with gastric cancer.
    Higuchi T; Nakamura T; Uchino H
    J Natl Cancer Inst; 1980 Nov; 65(5):897-900. PubMed ID: 6933259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver failure and drug metabolism.
    Andreasen PB; Ranek L
    Scand J Gastroenterol; 1975; 10(3):293-7. PubMed ID: 1138332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of acute and chronic propranolol administration on antipyrine and paracetamol clearance in patients with chronic liver disease.
    Hayes PC; Bouchier IA
    Am J Gastroenterol; 1989 Jul; 84(7):723-6. PubMed ID: 2741882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial prospective evaluation of cancer incidence in relation to metabolism of antipyrine and family history in patients with lung cancer].
    Radzikowska E; Oniszh K; Chojak E
    Pneumonol Alergol Pol; 1996; 64(1-2):45-9. PubMed ID: 8630464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of physical exercise on one-sample antipyrine clearance.
    Fabbri A; Bianchi G; Zoli M; Marchi E; Marchesini G
    Ital J Gastroenterol; 1991 Feb; 23(2):74-6. PubMed ID: 1747507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
    Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipyrine metabolism in lung cancer patients and their relatives.
    Radzikowska E; Gazdzik W; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():297-308. PubMed ID: 9337547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-subunit of human chorionic gonadotropin in bronchogenic carcinoma].
    Zatloukal P; Glagolicová A; Mĕricka O; Bezdícek P
    Sb Lek; 1993; 94(4):327-31. PubMed ID: 7527586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic ACTH production in carcinoma of the lung.
    Gewirtz G; Yalow RS
    J Clin Invest; 1974 Apr; 53(4):1022-32. PubMed ID: 4360854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.